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Supplementary Figure 1. The effectors Ssp1, Ssp2, Ssp4, Ssp5 and Ssp6 do not contribute to the 
anti-fungal activity of the Serratia marcescens Db10 Type VI secretion system. Shown is the 
number of recovered cells of Candida albicans SC5314 following co-culture with wild type (WT) or 
mutant (ΔtssE, Δtfe1 and Δssp1-ssp6) strains of S. marcescens Db10. Cells of C. albicans were also 
cultured in the presence of sterile media alone (media). Individual data points are overlaid with the 
mean +/- SEM (n=4 biological replicates). 
 
 
 
 
 
 
Supplementary Figure 2. Multi-scatter plots and histograms showing the reproducibility of the LFQ 
proteomics experiments. (a-c) Multi-scatter plots show high reproducibility between six individual 
biological replicate samples of S. marcescens Db10 (WT) (a), between six replicates of ΔtssE (b), and 
between Db10 and ΔtssE samples (c). The calculated Pearson correlation is displayed in blue. (d) Intensity 
distribution histograms of each replicate show log-normal distributions and equal loading of samples.  
 
 
 
 
 
 
 
 
 
Supplementary Figure 3. The anti-fungal effectors Tfe1 and Tfe2 do not contribute to function or 
anti-bacterial activity of the Type VI secretion system. (a) Loss of Tfe1 or Tfe2 does not affect T6SS-
dependent anti-bacterial activity against Pseudomonas fluorescens. Recovery of P. fluorescens 
following co-culture with wild type (WT) or mutant (ΔtssE, Δtfe1 and Δtfe2) strains of Serratia 
marcescens Db10 as attacker, or following culture with sterile media alone (media). (b) A mutant 
lacking the cognate ‘immunity protein’ for Tfe1, Sip3, is not susceptible to wild type S. marcescens. 
Recovery of different target strains of S. marcescens, wild type (WT, Db11), Δsip3 (KT69), Δsip3Δtfe1 
(KT98), or Δsip3Δtfe1 carrying the vector control plasmid (+VC, pBAD18Kn), following co-culture 
with attacking strains of S. marcescens Db10. These attackers were wild type Db10 (WT), the T6SS-
inactive mutant ΔtssH and the effector mutant Δtfe1, or the wild type carrying either the vector control 
plasmid (+VC) or a plasmid directing the expression of Tfe1 (+Tfe1, pSC1231) or of the immunity-
effector pair Sip3-Tfe1 (+Tfe1+Sip3, pSC1232). In each case, the target strain additionally carries 
streptomycin resistance (Supplementary Table 2). Inset, arrangement of sip3 and tfe1 (formerly known 
as ssp3) genes. (a,b) data points are overlaid with the mean +/- SEM (n=4 biological replicates). 
 
  
Supplementary Figure 4 
 
 
 
 
 
 
 
 
 
Supplementary Figure 4. The S. marcescens Type VI secretion system has no impact on 
cytotoxicity towards RAW264.7 cells. RAW264.7 macrophage-like cells were infected with strains 
of S. marcescens at a multiplicity of infection of 10:1 and lactate dehydrogenase (LDH) release 
measured after 2, 4 or 6 hours. Cytotoxicity is expressed as a percentage of the value of extracellular 
LDH obtained from total lysis of the RAW cells using 0.1% Triton X-100. Strains of S. marcescens 
used were were wild type Db10 (WT), a T6SS mutant (ΔtssE), a mutant unable to produce secreted 
haemolysin (shl), and the T6SS mutant in the haemolysin-null background (shl ΔtssE); as negative 
control no bacteria were added (untreated). The Shl haemolysin is the primary virulence factor of 
Serratia marcescens and thus could potentially have masked any T6SS-dependent effect. Three 
independent experiments are shown, with individual values from duplicate culture wells given. 
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Supplementary Figure 5. Cryo-TEM reveals Type VI secretion system-dependent necrosis and 
intimate association between cells of Candida albicans and Serratia marcescens. (a) Cryo-TEM 
images of multiple cells from co-cultures of C. albicans SC5314 with either wild type (left) or ΔtssE 
(right) S. marcescens Db10. Examples of necrotic C. albicans cells are indicated with white arrows. (b) 
Higher magnification image of two necrotic C. albicans cells. (c) Cryo-TEM images of individual cells 
from co-cultures of C. albicans with S. marcescens, showing a very tight interface between the bacterial 
and fungal cells. The white box shows an area enlarged in the adjacent panel. Images were acquired on 
one occasion and are representative of three sections and at least 60 C. albicans cells observed at high 
magnification. 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 6. The anti-bacterial effectors Ssp1 and Ssp2 do not cause toxicity upon 
artificial expression in yeast. Growth of S. cerevisiae K699 carrying the empty vector (pRB1438, 
control) or plasmids directing expression of Ssp1, Ssp2, Tfe1, Tfe2 or GFP on non-inducing (2% 
glucose) and inducing (2% raffinose) media. Representative of two independent experiments. 
  
 
 
 
 
 
 
 
 
 
Supplementary Figure 7. Tfe1 displays toxicity when artificially expressed in cells of C. albicans. 
(a) Growth of C. albicans SC5314 (control) and derivatives expressing GFP (+GFP, KT158), Tfe1 (+ 
Tfe1, KT159) or Tfe2 (+ Tfe2, KT160) on non-inducing and inducing media (dox, doxycycline). 
Representative of three independent experiments. (b) Fluorescence microscopy of C. albicans SC5314 
expressing Tfe1 or control protein GFP, and subjected to propidium iodide staining following a 3.5 h 
induction period. Shown are the single and merged GFP and propidium iodide channels, and their 
overlays on the corresponding DIC images. Representative of two independent experiments. Scale bar, 
25 µm. 
 
  
 
 
 
Supplementary Figure 8. Determination of the impact of Tfe1 and Tfe2 expression on membrane 
potential and permeability in Sacchromyces cerevisiae. (a) Phase contrast (top) and fluorescence 
microscopy of S. cerevisiae K699 cells stained with the potential-sensitive dye DiBAC4(3), which stains 
cells in a depolarisation-dependent manner (bottom). The strains used were K699 chromosomal 
integration strains harbouring the empty promoter construct (control) or derivatives expressing Tfe1 or 
Tfe2. The control cells were additionally treated with 10 µM mellitin (membrane depolarization through 
pore formation) or 3 µg/ml amphotericin B (membrane depolarization without pore formation) as 
positive controls. The large fluorescence images depict the cells with identical contrast settings. In the 
smaller inserts, the contrast of the fluorescence image is increased to reveal weakly stained cells. Scale 
bar, 8 µm. (b) As part a, but including co-staining with propidium iodide, which can cross permeabilised 
membranes, for control, Tfe1-expressing and mellitin-treated cells (bottom panel). Scale bar, 8 µm. (c) 
Cellular DiBAC4(3) and propidium iodide fluorescence values were quantified for control cells, those 
expressing Tfe1 or Tfe2, and those treated with mellitin or amphotericin B. Scatter plots depict 
fluorescence intensity values of individual cells for both dyes. Data shown are representative of two 
independent experiments. 
 
 
  
Supplementary Figure 9 
 
 
 
 
 
 
 
Supplementary Figure 9. Determination of the impact of Tfe1 and Tfe2 delivery on membrane 
potential and permeability of C. albicans when co-cultured with strains of S. marcescens. Phase 
contrast (top panels), and fluorescence microscopy of C. albicans SC5314 cells, following co-culture 
with the indicated strains of S. marcescens and co-staining with the potential-sensitive dye DiBAC4(3) 
which stains cells in a depolarisation-dependent manner (middle panels), and propidium iodide which 
can cross permeabilised membranes (bottom panels). The large fluorescence images depict the cells 
with identical contrast settings. In the smaller inserts, the contrast of the fluorescence image is 
increased to reveal weakly stained cells. Scale bar, 8 µm. Data shown are representative of two 
independent experiments. 
 
 
  
 
 
 
 
 
 
 
 
 
Supplementary Figure 10. Activity of the S. marcescens T6SS against hyphae of C. albicans 
measured using viable cell counting. Recovery of viable cells (colony forming units) of the 
constitutively filamentous mutant of C. albicans, tup1Δ, following co-culture with wild type or mutant 
(ΔtssE, Δtfe1, Δtfe2 and Δtfe1Δtfe2) strains of S. marcescens Db10. Note that, as observed in Figure 
4, only a fraction of individual cells within the hyphal filament are intoxicated, explaining why the 
T6SS-dependent reduction in viable cell counts is smaller than that observed using yeast form cells 
(Figure 1). Individual data points are overlaid with the mean +/- SEM (n=4 biological replicates) and 
p values are shown from unpaired, two-sided t-test. 
 
 
 
 
Supplementary Figure 11. Volcano plot of Candida albicans proteins from ‘in competition’ 
proteomics experiments. Volcano plots summarising the changes in C. albicans proteins following 
co-culture of C. albicans with wild type S. marcescens Db10 (WT) compared to co-culture with ΔtssE 
(a), Δtfe1 (b), Δtfe2 (c) or Δtfe1Δtfe2 (d) mutants, using TMT-based quantification (n=6 biological 
replicates). The log2 of the ratios of protein intensities between the wild type and the ΔtssE, Δtfe1, Δtfe2 
or Δtfe1Δtfe2 mutants are plotted against the -log10 of t-test p-values. Cut-off values of log2 ratios and 
-log10 of t-test p-value are represented in blue (± 1.3-fold) and orange (p-value =0.05), respectively.  
  
 
 
 
 
 
 
Supplementary Figure 12. Multi-scatter plots from ‘in competition’ proteomics experiment show 
high-reproducibility. Multi-scatter plots comparing the log2 intensities from the TMT-based MS3 
quantification of the C. albicans proteome after co-culture with wild type S. marcescens Db10 (WT) 
and with mutants ΔtssE, Δtfe1, Δtfe2 or Δtfe1Δtfe2 for all six biological replicates. The calculated 
Pearson correlation is displayed in blue, showing an excellent reproducibility between the different 
types of strains and replicates (Pearson correlation >0.95). 
 
  
  
 
 
Supplementary Figure 13. Intensity distribution histograms of Candida albicans proteins show 
the reproducibility of the ‘in competition’ proteomics experiments. Intensity distribution 
histograms of C. albicans proteins following co-culture with wild type S. marcescens Db10 (WT), 
ΔtssE, Δtfe1, Δtfe2 or Δtfe1Δtfe2 in six TMT replicates show log-normal distributions of the non-
normalised data and equal loading of samples.  
 
 
 
 
 
 
Supplementary Figure 14. Peptides and proteins quantified in each replicate of the ‘in 
competition’ proteomics experiments. Number of unique peptides (a) and proteins (b) identified and 
quantified over the six replicates. 
 
  
 
 
 
 
Supplementary Figure 15. Quantification data for Sul2, an example of a C. albicans transporter 
protein downregulated by Tfe2-mediated intoxication. (a) Extracted TMT intensities for unique 
individual peptides of Sul2 from total cellular protein samples from co-cultures of C. albicans with S. 
marcescens Db10 (WT), ΔtssE, Δtfe1, Δtfe2 or Δtfe1Δtfe2. Blue bars show the mean intensity values, 
error bars represent ± SEM with individual data points overlaid, and “N” states the number of 
quantifications of the peptide over the six injected TMT replicates. (b) Normalised extracted TMT 
intensity ratios from the seven Sul2 unique peptides in (a). Data are shown as mean ± SEM. 
 
 
 
 
Supplementary Figure 16. Intoxication of S. cerevisiae by T6SS-delivered Tfe2 results in a 
decrease in total levels of Can1 and its redistribution from the plasma membrane to the vacuole. 
(a) Immunoblot detection of Can1-GFP in S. cerevisiae BY4741 CAN1-GFP, when cultured alone or 
with wild type (WT) or mutant (ΔtssE, Δtfe2) strains of S. marcescens Db10. Pgk1 is included as a 
loading control; *, non-specific band; the full, uncropped blots can be found in Supplementary Fig. 18. 
Representative of three independent experiments. (b) Fluorescence microscopy of S. cerevisiae BY4741 
CAN1-GFP following culture alone or with strains of S. marcescens Db10 as indicated, and staining 
with the vacuolar dye CMAC. From top to bottom, panels show phase contrast, GFP fluorescence, 
CMAC fluorescence, and a merge of the GFP and CMAC channels. Scale bar, 8 µm. Representative of 
two independent experiments. (c) Quantification of the relative distribution of Can1-GFP fluorescence 
signal between an exterior (plasma membrane) location and an interior location (including the vacuole) 
for the co-cultures shown in part b. Left, schematic of manually defined cell areas (scale bar, 4 µm); 
right, quantitation for 30 randomly chosen yeast cells in each condition. Points represent individual 
cells and bars show mean (p values are indicated; unpaired, two-sided t-test). 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 17. Processing of GFP-Atg8 in response to Tfe2 is dependent on Atg13. 
Immunoblot detection of GFP-Atg8 processing in S. cerevisiae BY4742 or its mutant derivative atg13Δ, 
following co-culture with wild type (WT) or mutant (ΔtssE and Δtfe2) strains of S. marcescens Db10. 
Yeast cells carry either the reporter plasmid GFP-ATG8(416) directing expression of GFP-Atg8 from 
the endogenous Atg8 promoter, or the vector control (pRS316, VC). GFP-Atg8 has a MW of 41 kDa 
and cleaved GFP is 27 kDa. Pgk1 was used as control cellular protein and a dashed line indicates where 
the blot membrane was cut prior to detection with Pgk1 antibody; the full, uncropped blots can be found 
in Supplementary Fig. 18. Representative of two independent experiments. 
 
 
 
Supplementary Figure 18. Uncropped western blot images. MW markers are indicated (kDa). 
 
Supplementary Table 1. C. albicans proteins with altered abundance in response to T6SS-mediated delivery of Tfe2 
Protein ID 
 Relative abundance (log2 WT/mutant) 
Protein name Function 
Δtfe1 Δtfe2 Δtfe1Δtfe2 ΔtssE 
orf19.4654 -0.79  4.09  3.11  3.40 -  Protein of unknown function 
orf19.1358 -0.14  2.47  2.78  2.25 Gcn4  bZIP transcription factor, amino acid control response 
orf19.6222.1 -0.51  1.48  1.33  1.28 -  Protein of unknown function 
orf19.5620 -0.35  0.83  0.71  0.64 Phz1 (Yhi9) Protein of unknown function 
orf19.1340 -0.45  0.82  0.81  0.79 - (Ydl124w) Putative aldose reductase 
orf19.6689 -0.20  0.78  0.91  0.77 Arg4  Argininosuccinate lyase 
orf19.3841  0.37  0.72  0.61  0.67 Atg1  Putative protein Ser/Thr kinase, predicted role in autophagy and Cvt-pathway 
orf19.6514 -0.21  0.62  0.67  0.59 Cup9 (Tos8) Transcription factor 
orf19.3142 -0.23  0.56  0.44  0.43 -  Protein of unknown function 
orf19.6245 -0.24  0.55  0.66  0.58 -  Protein of unknown function 
orf19.5720 -0.05  0.55  0.60  0.59 - (Mch4) Predicted membrane transporter, member of the monocarboxylate porter family 
orf19.6994 -0.23  0.54  0.42  0.46 Bat22 (Bat2) Putative branched chain amino acid aminotransferase 
orf19.7469 -0.11  0.52  0.70  0.52 Arg1  Argininosuccinate synthase 
orf19.3770 -0.33  0.51  0.57  0.49 Arg8  Putative acetylornithine aminotransferase 
orf19.5645 -0.07 -0.39 -0.50 -0.39 Met15 (Met17) O-acetylhomoserine O-acetylserine sulfhydrylase 
orf19.4099  0.00 -0.43 -0.63 -0.45 Ecm17 (Met5) Putative beta subunit of assimilatory sulphite reductase  
orf19.2451  0.15 -0.46 -0.89 -0.58 Pga45 (-) Putative GPI-anchored cell wall protein 
orf19.6939  0.01 -0.47 -0.48 -0.46 -  Protein of unknown function 
orf19.6937  0.25 -0.50 -0.57 -0.52 Ptr22 (Ptr2) Oligopeptide transporter 
orf19.4076  0.00 -0.50 -0.70 -0.46 Met10  Putative alpha subunit of assimilatory sulphite reductase  
orf19.2661 -0.20 -0.50 -0.71 -0.68 Tlo34 (-) Protein of unknown function 
orf19.4077 -0.18 -0.56 -0.53 -0.58 Mit1 (Sur1) Mannosylinositol phosphorylceramide synthase catalytic subunit 
orf19.5642 -0.30 -0.63 -0.58 -0.81 - (Dif1) Putative protein regulating nuclear localization of Rnr2 and Rnr4 
orf19.5811  0.00 -0.68 -0.77 -0.61 Met1  Putative urophorphyrin-3 C-methyltransferase 
orf19.3642  0.33 -0.70 -0.45 -0.43 Sun41 (Sun4) Cell wall glycosidase 
orf19.6600 -0.10 -0.72 -1.11 -0.75 - (Ups1) Putative phosphatidic acid transporter activity 
orf19.2738  0.04 -1.08 -0.95 -1.09 Sul2 (Sul1) Sulfate transporter 
orf19.668 -0.20 -1.11 -0.96 -0.74 Tos4  Putative fork-head transcription factor 
orf19.97 -0.11 -1.34 -1.43 -0.97 Can1  Basic amino acid permease 
orf19.6993  0.08 -1.83 -1.62 -0.64 Gap2 (Gap1) General broad specificity amino acid permease 
Proteins are included on the basis of their abundance in the total cellular proteome of C. albicans being significantly altered upon co-culture with wild type S. marcescens Db10 
(WT) compared with the Δtfe2 mutant (fold change >1.3, significant t-test for the pairwise comparison (two-sided, p<0.05) and significant ANOVA score (p<0.05, multiple 
sample test) across all conditions), and also showing an equivalent change (>1.3-fold) when comparing the wild type with the Δtfe1Δtfe2 double mutant and the T6SS-inactive 
mutant ΔtssE (n=6). The table summarises the data from six independent biological replicates, analysed using six-plex TMT mass spectrometry, and changes in abundance are 
presented as log2 of WT/mutant. Protein names are according to the Candida Genome Database (CGD), with the S. cerevisiae homologue, where different, given in brackets. 
Fold change values greater than 1.3 are shown in purple and orange (increase or decrease, respectively) and entries are ordered according to changes in Δtfe2. It should be noted 
that TMT experiments suffer from ratio compression1 and the ratios are in reality probably higher than reported.
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Supplementary Table 2. Additional Gene Ontology (GO) analysis of Tfe2-dependent Candida 
albicans proteins. 
 
GOID GO_term Count P-value Gene(s) annotated to the term 
Cellular Component 
5886       Plasma membrane 17 0.0047 
C2_00940W_A, ZRT2, ITR1, RTA2, 
PTR22, GAP2, MET15, SUL2, RHD3, 
TNA1, CAG1, CTR1, CAN1, CAN2, 
C7_03350C_A, TPO4, SLP3 
9337       Sulfite reductase complex (NADPH) 2 0.0120 ECM17, MET10 
324       Fungal-type vacuole 12 0.0174 
NCR1, ITR1, ECM17, RTA2, MIT1, 
PTR22, GAP2, ATG1, TNA1, VTC3, 
TPO4, SLP3 
Molecular Function 
5215       Transporter activity 15 0.0031 
NCR1, ZRT2, ITR1, RTA2, PTR22, 
GAP2, SUL2, TNA1, GNP1, CTR1, 
CAN1, CAN2, C6_03540W_A, TPO4, 
CR_09620C_A 
  46943     Carboxylic acid transmembrane transporter activity 6 0.0060 
GAP2, TNA1, GNP1, CAN1, CAN2, 
C6_03540W_A 
    15181   Arginine transmembrane transporter activity 3 0.0031 GAP2, CAN1, CAN2 
    15193   L-proline transmembrane transporter activity 2 0.0137 GAP2, GNP1 
4783       Sulfite reductase (NADPH) activity 2 0.0137 ECM17, MET10 
Biological Process 
44281       Small molecule metabolic process 21 0.0029 
SNZ1, C1_02970W_A, DUR1,2, MET1, 
RNR21, LYS22, ECM17, BAT22, 
MET15, SPS20, ARG8, LYS1, 
C5_00800C_A, HAM1, CAR1, CAG1, 
ILS1, C7_03350C_A, ARG4, ARG1, 
VTC3 
  6082     Organic acid metabolic process 17 0.0003 
SNZ1, C1_02970W_A, MET1, LYS22, 
ECM17, BAT22, MET15, SPS20, 
ARG8, LYS1, C5_00800C_A, CAR1, 
CAG1, ILS1, ARG4, ARG1, VTC3 
    6520   Cellular amino acid metabolic process 14 0.0000 
SNZ1, C1_02970W_A, MET1, LYS22, 
ECM17, BAT22, MET15, ARG8, LYS1, 
C5_00800C_A, CAR1, ILS1, ARG4, 
ARG1 
      6525 Arginine metabolic process 4 0.0020 ARG8, CAR1, ARG4, ARG1 
      6591 Ornithine metabolic process 3 0.0192 ARG8, CAR1, ARG4 
0097       Sulfur amino acid biosynthetic process 5 0.0057 
SNZ1, C1_02970W_A, MET1, ECM17, 
MET15 
 
GO-Term analysis of the 76 proteins found to be differentially abundant (± 1.3-fold) in the total proteome of C. 
albicans when co-cultured with wild type S. marcescens compared with the Δtfe2 mutant. Proteins were 
included based on a single pairwise comparison, WT/Δtfe2 (p-value < 0.05, unpaired two-sided t-test; n=6 
biological replicates). Shown are enrichments in the three ontologies ‘cellular component’, ‘molecular function’ 
and ‘biological process’ (p-value ≤ 0.02), generated using the GO Term Finder tool at  the Candida gene 
database (http://www.candidagenome.org/). Arrows represent parent-child relationships and redundancies were 
curated manually. This analysis includes an extended set of Tfe2-dependent proteins compared with that 
depicted in Fig. 5b but identifies very similar areas of metabolism and cellular transport.  
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Supplementary Table 3. Strains and Plasmids used in this study. 
Name Description/ genotype Source / Reference 
Strains 
Serratia marcescens 
Db10 Wild type 2 
Db11 Spontaneous Sm-resistant derivative of Db10 2 
SJC11  Db10 ∆tssE (∆SMDB11_2271) 3 
SJC3 Db10 ∆tssH (∆SMDB11_2274) 3 
KT65 Db10 Δtfe1 (ΔSMDB11_1112) 4 
KT148 Db10 Δtfe2 (ΔSMDB11_1083) This study 
KT149 Db10 Δtfe1Δtfe2 (ΔSMDB11_1112, ΔSMDB11_1083) This study 
KT64 Db10 Δsip3 (ΔSMDB11_1111) This study 
KT69 Db10 Δsip3, Sm-resistant, derived from KT64a This study 
KT66 Db10 Δsip3Δtfe1 (ΔSMDB11_1111-1112) This study 
KT98 Db10 Δsip3Δtfe1, Sm-resistant, derived from KT66a This study 
MLM01 Db10 Δssp1-ssp6 (ΔSMDB11_2261, ΔSMDB11_2264, ΔSMDB11_1112, 
ΔSMDB11_3980, ΔSMDB11_4628, ΔSMDB11_4673) 
This study 
21C4 Db11  shlB::miniTn5-Cm  5 
YL23 Db10 shlB::miniTn5-Cm (shl) This study 
YL24 Db10 ∆tssE shlB::miniTn5-Cm (shl ∆tssE) This study 
Pseudomonas fluorescens 
KT02 Sm-resistant derivative of P. fluorescens 55 3 
Escherichia coli 
CC118λpir Cloning host and donor for pKNG101-based allelic exchange plasmids (λpir) 6 
HH26 
pNJ5000 
Mobilizing strain for conjugal transfer 7 
Saccharomyces cerevisiae   
K699 MATa ade2-1 trp1-1 leu2-3,112 his3-11,15 ura3 can1-100 8 
BH01 K699 his3::PGAL1b This study 
KT164 K699 his3::PGAL1-GFPb This study 
KT165 K699 his3::PGAL1-SMDB11_1083b This study 
KT167 K699 his3::PGAL1-SMDB11_1112b This study 
BY4742 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 9 
atg13Δ BY4742 atg13∆::kanMX6 SGDC 
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 9 
Can1-GFP BY4741 CAN1-GFP::his5+ 10 
Candida albicans   
SC5314 Wild type clinical isolate 11 
KT158 SC5314 ADH1/adh1::Ptet-caGFPc  This study 
KT159 SC5314 ADH1/adh1::Ptet-caSMDB11_1112c This study 
KT160 SC5314 ADH1/adh1::Ptet-caSMDB11_1083c This study 
tup1Δ arg4∆/arg4∆ leu2∆/leu2∆ his1∆/his1∆ URA3/ura3∆::imm434 
IRO1/iro1∆::imm434 tup1∆::HIS1/tup1∆::LEU2 
12 
Candida glabrata   
ATCC2001 Wild type ATCC 
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Plasmids 
pKNG101 Suicide vector for allelic exchange (SmR sacBR mobRK2 oriR6K) 13 
pSC1249 pKNG101-derived allelic exchange plasmid for the generation of chromosomal 
in-frame ΔSMDB11_1112 (Δtfe1) deletion 
4 
pSC1339 pKNG101-derived allelic exchange plasmid for the generation of chromosomal 
in-frame ΔSMDB11_1083 (Δtfe2) deletion 
This study 
pSC1248 pKNG101-derived allelic exchange plasmid for the generation of chromosomal 
in-frame ΔSMDB11_1111 (Δsip3) deletion 
This study 
pSC1250 pKNG101-derived allelic exchange plasmid for the generation of chromosomal 
in-frame ΔSMDB11_1111-1112 (Δsip3Δtfe1) deletion 
This study 
pSC123 pKNG101-derived allelic exchange plasmid for the generation of chromosomal 
in-frame ΔSMDB11_2261 (Δssp1) deletion 
14 
pSC125 pKNG101-derived allelic exchange plasmid for the generation of chromosomal 
in-frame ΔSMDB11_2264 (Δssp2) deletion 
14 
pSC828 pKNG101-derived allelic exchange plasmid for the generation of chromosomal 
in-frame ΔSMDB11_3980 (Δssp4) deletion 
4 
pSC829 pKNG101-derived allelic exchange plasmid for the generation of chromosomal 
in-frame ΔSMDB11_4628 (Δssp5) deletion 
4 
pSC1241 pKNG101-derived allelic exchange plasmid for the generation of chromosomal 
in-frame ΔSMDB11_4673 (Δssp6) deletion 
4 
pSUPROM Vector for constitutive expression of cloned genes under the control of the E. 
coli tat promoter (KnR) 
4 
pSC1332 pSUPROM-derived plasmid for constitutive expression of SMDB11_1111-1112 
(sip3-tfe1) 
This study 
pSC1343 pSUPROM-derived plasmid for constitutive expression of SMDB11_1083 (tfe2) This study 
pBAD18-Kn Vector for arabinose-inducible expression of cloned genes under the control of 
the Para promoter  
15 
pSC1231 pBAD18-Kn-derived plasmid for arabinose-inducible expression of 
SMDB11_1112 (tfe1) 
4 
pSC1232 pBAD18-Kn-derived plasmid for arabinose-inducible expression of 
SMDB11_1111-1112 (sip3-tfe1) 
4 
pNIM1 Tetracycline-inducible expression vector for integration into C. albicans (ADH1 
locus) carrying the caGFP gene (NatR, AmpR) 
16 
pSC1352 pNIM-derived plasmid for Tetracycline-inducible expression of 
caSMDB11_1112d (caTFE1) 
This study 
pSC1354 pNIM-derived plasmid for Tetracycline-inducible expression of 
caSMDB11_1083d (caTFE2) 
This study 
pRB1438 Yeast expression vector carrying the bi-directional Gal1,10 promoter element 
(URA3, CEN, AmpR) 
D. Botstein 
pUG23 Yeast expression vector carrying yEGFP3 under MET25 promoter (HIS3, CEN, 
AmpR) 
17 
pSC1356 pRB1438-derived plasmid for galactose-inducible expression (PGAL1) of 
yEGFP3 derived from pUG23 
This study 
pSC1296 pRB1438-derived plasmid for galactose-inducible expression (PGAL1) of 
SMDB11_1112 (TFE1)  
This study 
pSC1357 pRB1438-derived plasmid for galactose-inducible expression (PGAL1) of 
SMDB11_1083 (TFE2) 
This study 
pSC1834 pRB1438-derived plasmid for galactose-inducible expression (PGAL1) of 
SMDB11_2261 (SSP1)  
This study 
pSC1832 pRB1438-derived plasmid for galactose-inducible expression (PGAL1) of 
SMDB11_2264 (SSP2)  
This study 
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a Streptomycin-resistant derivatives were generated by phage ϕIF3-mediated transduction of the resistance allele 
from S. marcescens Db11, as described previously14 
b The whole cassette containing the indicated target gene under control of the GAL1 promoter and the LEU2 
selection marker was inserted into the HIS3 allele. 
cThe whole cassette containing rtTA under control of the ADH1 promoter, the caSAT1 selection marker, and the 
indicated target gene under control of the Tet-inducible promoter was inserted into one of the ADH1 alleles. 
d CDS was codon optimised for expression in C. albicans 
pGED1 Constitutive expression vector for integration into S. cerevisiae HIS3 locus 
(LEU2, AmpR) 
G. Eitzen 
pSC1384 pGED1 derived plasmid carrying empty PGAL1 promoter construct (integrative) This study 
pSC1379 pGED1 derived plasmid for galactose-inducible expression (PGAL1) of yEFGP3 
(integrative) 
This study 
pSC1382 pGED1 derived plasmid for galactose-inducible expression (PGAL1) of 
SMDB11_1112 (TFE1) (integrative) 
This study 
pSC1380 pGED1 derived plasmid for galactose-inducible expression (PGAL1) of 
SMDB11_1083 (TFE2) (integrative) 
This study 
GFP-
ATG8(416) 
pRS416-derived plasmid for expression of N-terminal GFP-tagged ATG8 under 
the control of the endogenous promoter (URA3, CEN, AmpR), Addgene # 49425 
18 
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Supplementary Table 4. Oligonucleotide primers and additional details for plasmid 
construction, primers for Southern blot probe generation and primers for qPCR. 
Plasmid Sequence of relevant primers (5’-3’)1 Description 
pSC1339 TATATCTAGAGTGCCGATCGATATTGAAGAGG Forward primer to clone upstream region of 
SMDB11_1083 in pKNG101 (XbaI) 
 TATAAAGCTTTGGCATAGCTGCCCCTC Reverse primer to clone upstream region of 
SMDB11_1083 in pKNG101 (HindIII) 
 TATAAAGCTTCAGGCTGGATAAGCCTTTCCC Forward primer to clone downstream region of 
SMDB11_1083 in pKNG101 (HindIII) 
 TATAGTCGACGTTTGGCACCAACCCCATC Reverse primer to clone downstream region of 
SMDB11_1083 in pKNG101 (SalI) 
pSC1248 TATAGGATCCGACAAAAATGACGG Forward primer to clone upstream region of 
SMDB11_1111 in pKNG101 (BamHI) 
 TATAAAGCTTCGGCTGCATAACCACCC Reverse primer to clone upstream region of 
SMDB11_1111 in pKNG101 (HindIII) 
 TATAAAGCTTCTAGAGGGTGAAGAGGACAGTCCC Forward primer to clone downstream region of 
SMDB11_1111 in pKNG101 (HindIII) 
 TATAGTCGACGCAACGGCGGGTTTAAATAAGG Reverse primer to clone downstream region of 
SMDB11_1111 in pKNG101 (SalI) 
pSC1250 TATAGGATCCGACAAAAATGACGG Forward primer to clone upstream region of 
SMDB11_1111 in pKNG101 (BamHI) 
 TATAAAGCTTCGGCTGCATAACCACCC Reverse primer to clone upstream region of 
SMDB11_1111 in pKNG101 (HindIII) 
 TATAAAGCTTGCCTGAGCCGGTCCG Forward primer to clone downstream region of 
SMDB11_1112 in pKNG101 (HindIII) 
 TATAGTCGACCTTGTGGCCACCGTCACC Reverse primer to clone downstream region of 
SMDB11_1112 in pKNG101 (SalI) 
pSC1332 TATAGGATCCGTGGTTATGCAGCCGTATAAAGAGG Forward primer to clone SMDB11_1111-1112 in 
pSUPROM (BamHI) 
 TATAAAGCTTCAGGCGGGGAAAGGCC Reverse primer to clone SMDB11_1111-1112 in 
pSUPROM (HindIII) 
pSC1343 TATAGGATCCATGCCATTAGAAGTCGATGGG Forward primer to clone SMDB11_1083 in 
pSUPROM (BamHI) 
 TATAAAGCTTTTATCCAGCCTGAGCCAGATC Reverse primer to clone SMDB11_1083 in 
pSUPROM (HindIII) 
pSC1309 GCCAGTTCCATGGCCTACCTTAGTCACTAC   Forward primer for QC to delete MscI site in 
yEGFP3 (pUG23) 
 GTAGTGACTAAGGTAGGCCATGGAACTGGC   Reverse primer for QC to delete MscI site in 
yEGFP3 (pUG23) 
pSC1356 TATAGGATCCATGTCTAAAGGTGAAGAATTATTCACTGG Forward primer to clone yEGFP3 (pSC1309) in 
pRB1438 (BamHI) 
 TATATCTAGATTATTTGTACAATTCATCCATACCATGG Reverse primer to clone yEGFP3 (pSC1309) in 
pRB1438 (XbaI) 
pSC1296 TATAGGATCCATGCATTGGTTGAATTTCAAG Forward primer to clone SMDB11_1112 in 
pRB1438 (BamHI) 
 TATAGAGCTCAGGCGGGGAAAGG Reverse primer to clone SMDB11_1112 in 
pRB1438 (SacI) 
pSC1357 TATAGGATCCATGCCATTAGAAGTCGATGGG Forward primer to clone SMDB11_1083 in 
pRB1438 (BamHI) 
 TATATCTAGATTATCCAGCCTGAGCCAGATC Reverse primer to clone SMDB11_1083 in 
pRB1438 (XbaI) 
pSC1834 TATAGGATCCATGAAACCTTTATATCGTCAGCTAAAAAG
C 
Forward primer to clone SMDB11_2261 in 
pRB1438 (BamHI) 
 TATATCTAGACTAGCTCAACTCCCAAAACCAGAC Reverse primer to clone SMDB11_2261 in 
pRB1438 (XbaI) 
pSC1832 TATAGGATCCATGAGTCGCCCTTCATTCCAAC Forward primer to clone SMDB11_2264 in 
pRB1438 (BamHI) 
 TATATCTAGATTATTTTAGTAACCATATAGATGCCTCGTT
G 
Reverse primer to clone SMDB11_2264 in 
pRB1438 (XbaI) 
pSC1384 TATAAGATCTCCTTGAATTTTCAAAAATTCTTAC Forward primer to clone PGAL1 in pGED1 (BglII) 
 TATAGCATGCTTAGGATCCGGGGTTTTTTCTC Reverse primer to clone PGAL1 in pGED1 (SphI) 
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pSC1379 TATAAGATCTCCTTGAATTTTCAAAAATTCTTAC Forward primer to clone PGAL1-yEGFP3 
(pSC13756 in pGED1 (BglII) 
 TATAGCATGCTTATTTGTACAATTCATCCATACCATGG Reverse primer to clone PGAL1-yEGFP3 
(pSC1356) in pGED1 (SphI) 
pSC1376 CAGCGGGGAGATGGCCTGGGATGCGGTG Forward primer for QC to delete SphI site in 
SMDB11_1112 (pSC1296) 
 CACCGCATCCCAGGCCATCTCCCCGCTG Reverse primer for QC to delete SphI site in 
SMDB11_1112 (pSC1296) 
pSC1382 TATAAGATCTCCTTGAATTTTCAAAAATTCTTAC  Forward primer to clone PGAL1-SMDB11_1112 
in pGED1  (BglII)(pSC1376) 
 TATAGCATGCTCAGGCGGGGAAAGGCC Reverse primer to clone PGAL1-SMDB11_1112 in 
pGED1 (SphI)(pSC1376) 
pSC1380 TATAAGATCTCCTTGAATTTTCAAAAATTCTTAC 
 
Forward primer to clone PGAL1-SMDB11_1083 
in pGED1 (BglII)(pSC1357) 
 TATAGCATGCTTATCCAGCCTGAGCCAGATC 
 
Reverse primer to clone PGAL1-SMDB11_1083 in 
pGED1 (SphI)(pSC1357) 
pSC1352 Synthetic insert produced by Life Technologies of the coding sequence of SMDB11_1112 with all CTG to TTG codon 
exchanges, cloned into pNIM1 (SalI, BglII) 
pSC1354 Synthetic insert produced by Life Technologies of the coding sequence of SMDB11_1083 with all CTG to TTG codon 
exchanges, cloned into pNIM1 (SalI, BglII) 
pGED1 PTEF-NAT1-TTEF (SalI, EcoRI) cut from pAG2519 was cloned into Ylplac12820 with subsequent introduction of a 
synthetic HIS3 fragment carrying residues 495-623 followed by residues 209-304 of the HIS3 CDS (HindIII, SalI). 
Both HIS3 regions are joined by a unique MscI site for linearization to facilitate homologous recombination. 
Southern Blot Probe generation 
Probe1 TGATAGAGACCCAATGCAAAGCC Forward primer to generate probe1, situated in 
homologues region 1 of pNIM1 (ADH1 promoter) 
 GGCACGAGACGGAAACTCTTTAGG Reverse primer to generate probe1, situated in homologues 
region 1 of pNIM1 (ADH1 promoter) 
Probe2 
 
GGTTTATCTGACTTGCCAGAAGTCTTC Forward primer to generate probe2, situated downstream 
of homologues region 2 of pNIM1 (ADH1 terminator) 
 CAGGACCAATCAAGCAATTCAG Reverse primer to generate probe2, situated downstream of 
homologues region 2 of pNIM1 (ADH1 terminator) 
qPCR   
ACT1 CAAGGTATCATGGTCGGTATGG Forward primer for qPCR of ACT1 
 CGTGTTCAATTGGGTAACGTAAAG Reverse primer for qPCR of ACT1 
AGP1 CGCCATATGTCATTGCTGTTG Forward primer for qPCR of AGP1 
 ACTGGAGTAGAAGGAGGAGTTAG Reverse primer for qPCR of AGP1 
GNP1 TTGCTAACGGTGCCTTCTATAC Forward primer for qPCR of GNP1 
 AGCAGGTCTACCTTCCCTATC Reverse primer for qPCR of GNP1 
BAP2 GAGGATGGCGTTGAGTCTATC Forward primer for qPCR of BAP2 
 GTCCCAATACCTGTCCCTAAAG Reverse primer for qPCR of BAP2 
BAP3 AGGAATCTCGCAATGGGTTAG Forward primer for qPCR of BAP3 
 ATTTGGTACCATCCTCCAAGTC Reverse primer for qPCR of BAP3 
DIP5 AACCCTGGTGTGTGGATTAC Forward primer for qPCR of DIP5 
 GACCCAACATTACCATGACTTTG Reverse primer for qPCR of DIP5 
CAN1 CGAGAGTAAATGGCGAGGATAC Forward primer for qPCR of CAN1 
 TACCACCAAGGGCAATCATAC Reverse primer for qPCR of CAN1 
PTR2 GGCTGTTGCCTGCTTTATTTC Forward primer for qPCR of PTR2 
 TCGTAGTCCATAGCGTTCATTTC Reverse primer for qPCR of PTR2 
SSY1 GTGGCGATCCAAGACTACTATC Forward primer for qPCR of SSY1 
 GTCCTAAGTCTCCAGTCCATTC Reverse primer for qPCR of SSY1 
STP1 GGCCATTCCAGGCAAGATATAC  Forward primer for qPCR of STP1 
 TCTTTGCCTTCCTCCTTTGTC  Reverse primer for qPCR of STP1 
STP2 CCAATGTGGAAGACGACAAATC  Forward primer for qPCR of STP2 
 AGCAGTCTTTCTGTGGATGG  Reverse primer for qPCR of STP2 
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SUL1 GGGTTGGGTATACTGCGTTTAG Forward primer for qPCR of SUL1 
 CCATGAGAGCCGGAATTTGA Reverse primer for qPCR of SUL1 
SUL2 ACGGTGAAAGGAGCATGTAG Forward primer for qPCR of SUL2 
 CTGCAATAAGATCCGCAGTAAAC Reverse primer for qPCR of SUL2 
GCN4 CGATGTTTCATTGGCTGATAAGG Forward primer for qPCR of GCN4 
 TCTAGAACAGGAGTGGGTAAGA Reverse primer for qPCR of GCN4 
1Incorporated restriction sites for cloning into the respective vector are underlined. 
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